4528.T ONO PHARMACEUTICAL CO | JP3197600004
Financials
Trends
Details
| Breakdown | 31.03.2028 | 31.03.2027 | Change % |
|---|---|---|---|
| Total Revenue | 444.471.428.330 | 454.302.480.830 | 2.16% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 133,02 | 151,00 | 11.91% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 11 | 11 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |